InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,408.42
(
-1.73%
)
US TECH 100
17,870.94
(
-3.09%
)
Dow Jones
40,345.41
(
-1.01%
)
Brent Oil
70.89
(
0.00%
)
Bitcoin
54,202.86
(
0.05%
)
Post# of 20617
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Honeycomb777

Send PM Follow Ignore
Followers 105
Posts 20514
Boards Moderated 0
Alias Born 06/30/2012

Honeycomb777

Re: None

Tuesday, 05/30/2017 5:21:03 PM

Tuesday, May 30, 2017 5:21:03 PM

Post# of 20617
5 near-term catalysts to consider:

- Announcement of EU distribution deals / Upfront money

- Results release of recent Vesele/Viagra study. Vesele sales will skyrocket IMO

- New Product launches (plus new distribution channels)...still at least 4 to come in 2017

- June 19, 2017 is the Annual Shareholder meeting. Higher PPS = Higher Morale

- FlutiCare FDA approval of ANDA (Novalere). A 2nd manufacturer !

Tweet Tweet


** Note - help yourself by NOT setting Stop Loss orders. Also, set Sell Stops in multiple dollars to "mark" your shares ! Low floater folks
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up